These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10881014)

  • 1. No responses to oral etoposide in 15 patients with recurrent brain tumors.
    Korones DN; Fisher PG; Cohen KJ; Dubowy RL
    Med Pediatr Oncol; 2000 Jul; 35(1):80-2. PubMed ID: 10881014
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with oral etoposide for childhood recurrent ependymomas.
    Sandri A; Massimino M; Mastrodicasa L; Sardi N; Bertin D; Basso ME; Todisco L; Paglino A; Perilongo G; Genitori L; Valentini L; Ricardi U; Gandola L; Giangaspero F; Madon E
    J Pediatr Hematol Oncol; 2005 Sep; 27(9):486-90. PubMed ID: 16189442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors.
    Needle MN; Molloy PT; Geyer JR; Herman-Liu A; Belasco JB; Goldwein JW; Sutton L; Phillips PC
    Med Pediatr Oncol; 1997 Jul; 29(1):28-32. PubMed ID: 9142202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
    Chamberlain MC
    Pediatr Neurol; 2001 Feb; 24(2):117-21. PubMed ID: 11275460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral etoposide for refractory and relapsed neuroblastoma.
    Kushner BH; Kramer K; Cheung NK
    J Clin Oncol; 1999 Oct; 17(10):3221-5. PubMed ID: 10506622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
    Terasaki M; Bouffet E; Katsuki H; Fukushima S; Shigemori M
    Surg Neurol; 2008 Jan; 69(1):46-50. PubMed ID: 18054615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of recurrent medulloblastoma to low-dose oral etoposide.
    Ashley DM; Meier L; Kerby T; Zalduondo FM; Friedman HS; Gajjar A; Kun L; Duffner PK; Smith S; Longee D
    J Clin Oncol; 1996 Jun; 14(6):1922-7. PubMed ID: 8656261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old drugs still work! Oral etoposide in a relapsed medulloblastoma.
    Perez-Somarriba M; Andión M; López-Pino MA; Lavarino C; Madero L; Lassaletta A
    Childs Nerv Syst; 2019 May; 35(5):865-869. PubMed ID: 30707305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors.
    Pajtler KW; Tippelt S; Siegler N; Reichling S; Zimmermann M; Mikasch R; Bode U; Gnekow A; Pietsch T; Benesch M; Rutkowski S; Fleischhack G
    J Neurooncol; 2016 Jul; 128(3):463-71. PubMed ID: 27147083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
    Korones DN; Smith A; Foreman N; Bouffet E
    Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
    Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
    Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology.
    Kucukoner M; Isikdogan A; Yaman S; Gumusay O; Unal O; Ulas A; Elkiran ET; Kaplan MA; Ozdemir N; Inal A; Urakci Z; Buyukberber S
    Asian Pac J Cancer Prev; 2012; 13(8):3973-6. PubMed ID: 23098502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second temporal remission in a malignant glioma with trofosfamide and etoposide: a case report.
    Wolff JE; Boos J; Krähling KH; Jürgens H
    Klin Padiatr; 1996; 208(4):190-2. PubMed ID: 8776706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study.
    Rose PG; Blessing JA; Soper JT; Barter JF
    Gynecol Oncol; 1998 Aug; 70(2):267-71. PubMed ID: 9740703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid pharmacokinetics after different dosage regimens of intraventricular etoposide.
    Sirisangtragul C; Henke G; Fleischhack G; Reif S; Kloft C; Bode U; Jaehde U
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):606-7. PubMed ID: 14692713
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose etoposide in the treatment of relapsed primary brain tumors.
    Finn GP; Bozek T; Souhami RL; Slevin ML; Thomas DG
    Cancer Treat Rep; 1985 Jun; 69(6):603-5. PubMed ID: 4016766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide.
    Donzé C; Revon-Rivière G; Pondrom M; Verschuur A; Leblond P; André N
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31076. PubMed ID: 38778441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral etoposide in relapsed or refractory Ewing sarcoma: a monoinstitutional experience in children and adolescents.
    Podda MG; Luksch R; Puma N; Gandola L; Morosi C; Terenziani M; Ferrari A; Casanova M; Spreafico F; Meazza C; Catania S; Schiavello E; Biassoni V; Chiaravalli S; Massimino M
    Tumori; 2016; 102(1):84-8. PubMed ID: 26797935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral etoposide for refractory or recurrent epithelial ovarian cancer.
    Thavaramara T; Tangjitgamol S; Manusirivithaya S; Leelahakorn S
    J Med Assoc Thai; 2009 Nov; 92(11):1397-405. PubMed ID: 19938729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.